Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C33H44N6O5 |
Molecular Weight | 604.7397 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C2=NC3=CC=CC=C3C=C2)C(=O)NC(C)(C)C
InChI
InChIKey=ZILOOGIOHVCEKS-HZFUHODCSA-N
InChI=1S/C33H44N6O5/c1-21(2)19-39(32(44)38-33(3,4)5)20-28(40)26(17-22-11-7-6-8-12-22)36-31(43)27(18-29(34)41)37-30(42)25-16-15-23-13-9-10-14-24(23)35-25/h6-16,21,26-28,40H,17-20H2,1-5H3,(H2,34,41)(H,36,43)(H,37,42)(H,38,44)/t26-,27-,28+/m0/s1
Molecular Formula | C33H44N6O5 |
Molecular Weight | 604.7397 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Telinavir (previously known as SC-52151) was developed as an anti-HIV aspartyl protease inhibitor for the treatment of HIV Infections. Telinavir participated in Phase I/II clinical study. In spite of the drug was well tolerated no antiviral activity was produced and further development of the drug was discontinued.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. | 1995 Apr 6 |
|
In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors. | 1997 May |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9215651
Forty-nine patients received the elixir or self-emulsifying drug delivery system at a dosage of 750 mg three times daily or 1125 mg twice daily for 14 days
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:58 GMT 2023
by
admin
on
Fri Dec 15 16:16:58 GMT 2023
|
Record UNII |
IZF55EH3CG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C97366
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
382974
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
100000082442
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
SUB10872MIG
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
DTXSID60931785
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
GG-69
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
670881
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
IZF55EH3CG
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
143224-34-4
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL322241
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
7372
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
C76911
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY | |||
|
DB12178
Created by
admin on Fri Dec 15 16:16:58 GMT 2023 , Edited by admin on Fri Dec 15 16:16:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|